Gaffin David Joseph
Transaction: 07/06/2026
SELL
Change
-2,034
Price
$54.03
Filing
07/06/2026
Type
SELL
Alkermes plc
ALKS • Biotechnology
$46.10
▼ -0.78 (-1.66%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHLY FAVORABLE PROFILEExcellentConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$8.11B
Growth
9.5%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Stable or improving margins · 16.4%Positive revenue growth · 5.3%Positive free cash flow · 2.92Consistent free cash flow · 4/5Reasonable earnings multiple · 19.07
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$46.10
Change-1.66%
Market Cap$8.11B
52W Range25.17 - 55.67
Beta0.29
Gross Margin86.69%
Oper. Margin17.21%
Profit Margin16.37%
Debt/Eq0.04
Current Ratio3.55
Quick Ratio3.19
Revenue 5Y9.50%
Price$46.10
Change-1.66%
Market Cap$8.11B
52W Range25.17 - 55.67
Beta0.29
Gross Margin86.69%
Oper. Margin17.21%
Profit Margin16.37%
Debt/Eq0.04
Current Ratio3.55
Quick Ratio3.19
Revenue 5Y9.50%
Target$55.86
Target Upside21.17%
Target Median$56.00
Target Range43.00 - 65.00
Volume4.07M
Avg Volume2.27M
EPS Surprise0.17
Investment DNA
How strong this company looks for long-term investors
85
out of 100
Business Quality
Margins, moat, returns
82/100
Financial Strength
Debt, cash, stability
95/100
Growth Potential
Revenue and expansion
83/100
Price Attractiveness
Cheap or expensive today
80/100
Why this score▼
Stable or improving margins · 16.4%Positive revenue growth · 5.3%Positive free cash flow · 2.92Consistent free cash flow · 4/5Reasonable earnings multiple · 19.07Manageable debt level · 0.04
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-07-30
Low
$43.00
Mean
$55.86
Median
$56.00
High
$65.00
Insider Transactions
Recent executive and insider activity
Hopkinson Craig C.
Transaction: 07/01/2026
SELL
Change
-5,000
Price
$19.34
Filing
07/01/2026
Type
SELL
Hopkinson Craig C.
Transaction: 07/01/2026
SELL
Change
-700
Price
$52.13
Filing
07/01/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Gaffin David Joseph | SELL | -2,034 | $54.03 | 07/06/2026 | 07/06/2026 |
| Hopkinson Craig C. | SELL | -5,000 | $19.34 | 07/01/2026 | 07/01/2026 |
| Hopkinson Craig C. | SELL | -700 | $52.13 | 07/01/2026 | 07/01/2026 |
| Wright Christopher I | SELL | -2,000 | $45.10 | 06/12/2026 | 06/12/2026 |
| Gaffin David Joseph | SELL | -2,034 | $43.05 | 06/04/2026 | 06/04/2026 |
| Hopkinson Craig C. | SELL | -5,000 | $19.34 | 06/01/2026 | 06/01/2026 |
| Hopkinson Craig C. | SELL | -9,000 | $41.67 | 06/01/2026 | 06/01/2026 |
| Parisi Samuel Joseph | SELL | -3,392 | $20.03 | 05/29/2026 | 05/29/2026 |
| Parisi Samuel Joseph | SELL | -16,217 | $42.36 | 05/29/2026 | 05/29/2026 |
| Cooke Shane | SELL | -6,142 | Not reported | 05/21/2026 | 05/22/2026 |
| Cooke Shane | SELL | -3,207 | $36.95 | 05/21/2026 | 05/22/2026 |
| GAYNOR RICHARD | SELL | -6,142 | Not reported | 05/21/2026 | 05/22/2026 |
| GAYNOR RICHARD | SELL | -1,475 | $36.95 | 05/21/2026 | 05/22/2026 |
| LAURENCIN CATO T | SELL | -6,142 | Not reported | 05/21/2026 | 05/22/2026 |
| LAURENCIN CATO T | SELL | -1,475 | $36.95 | 05/21/2026 | 05/22/2026 |
| Lurker Nancy | SELL | -6,142 | Not reported | 05/21/2026 | 05/22/2026 |
| Lurker Nancy | SELL | -1,475 | $36.95 | 05/21/2026 | 05/22/2026 |
| MCKEON BRIAN P | SELL | -6,142 | Not reported | 05/21/2026 | 05/22/2026 |
| MCKEON BRIAN P | SELL | -1,475 | $36.95 | 05/21/2026 | 05/22/2026 |
| snyderman nancy lynn MD | SELL | -6,142 | Not reported | 05/21/2026 | 05/22/2026 |